ATE444073T1 - Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten - Google Patents

Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Info

Publication number: ATE444073T1
Authority: AT; Austria
Prior art keywords: oxalate; degrading; preventing; related diseases; bacteria
Prior art date: 1997-05-23

Application number

AT98923673T

Other languages

English (en)

Inventor

Milton Allison

Harmeet Sidhu

Original Assignee

Oxthera Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-23

Filing date

1998-05-22

Publication date

2009-10-15

1998-05-22 Application filed by Oxthera Inc filed Critical Oxthera Inc

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE444073T1 publication Critical patent/ATE444073T1/de

Links

102000004190 Enzymes Human genes 0.000 title abstract 3
108090000790 Enzymes Proteins 0.000 title abstract 3
201000010099 disease Diseases 0.000 title abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
244000005700 microbiome Species 0.000 title 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 4
241000894006 Bacteria Species 0.000 abstract 3
210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
238000010521 absorption reaction Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT98923673T 1997-05-23 1998-05-22 Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten ATE444073T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4747397P	1997-05-23	1997-05-23
PCT/US1998/010495 WO1998052586A1 (en)	1997-05-23	1998-05-22	Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease

Publications (1)

Publication Number	Publication Date
ATE444073T1 true ATE444073T1 (de)	2009-10-15

Family

ID=21949193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98923673T ATE444073T1 (de)	1997-05-23	1998-05-22	Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Country Status (12)

Country	Link
US (1)	US6200562B1 (de)
EP (2)	EP0983076B1 (de)
JP (2)	JP4996780B2 (de)
KR (1)	KR20010012845A (de)
AT (1)	ATE444073T1 (de)
AU (1)	AU7590798A (de)
CA (1)	CA2288709C (de)
CY (1)	CY1109695T1 (de)
DE (1)	DE69841200D1 (de)
ES (1)	ES2334409T3 (de)
PT (1)	PT983076E (de)
WO (1)	WO1998052586A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355242B1 (en) *	1997-05-23	2002-03-12	Ixion Biotechnology, Inc.	Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) *	1997-05-23	2013-07-16	Oxthera, Inc.	Compositions and methods for treating or preventing oxalate-related disease
US20040120941A1 (en) *	1997-05-23	2004-06-24	Allison Milton J.	Materials and methods for treating or preventing oxalate-related disease
IT1309427B1 (it)	1999-05-28	2002-01-23	Mendes S U R L	Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
US7192609B2 (en)	2001-04-23	2007-03-20	Shire International Licensing B.V.	Use of rare earth compounds for the prevention of kidney stone disease
US20030113308A1 (en) *	2001-10-05	2003-06-19	Harmeet Sidhu	Materials and methods for reducing oxalate concentrations in fluids
US6929940B1 (en)	2002-08-20	2005-08-16	University Of Florida Research Foundation, Inc.	Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
EP1755655A4 (de) *	2004-05-07	2011-03-30	Oxthera Inc	Verfahren und zusammensetzungen zum reduzieren von oxalatkonzentrationen
WO2006047680A2 (en) *	2004-10-27	2006-05-04	North Carolina State University	Lactobacillus acidophilus nucleic acids and uses thereof
EP1928551B1 (de)	2005-06-10	2012-05-30	Althea Technologies, Inc.	Verfahren zur reduzierung der oxalat-konzentration durch verabreichung von oxalat-oxidase-kristallen
WO2007070052A2 (en) *	2005-12-14	2007-06-21	Oxthera, Inc.	Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2007075447A2 (en) *	2005-12-16	2007-07-05	Oxthera, Inc.	Compositions and methods for oxalate reduction
US8431122B2 (en)	2009-07-02	2013-04-30	Oxthera Intellectual Property Ab	Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
AU2010324830B2 (en)	2009-11-25	2016-04-14	Orenzymes Llc	Methods and compositions for treating oxalate-related conditions
JOP20200118A1 (ar)	2013-07-05	2017-06-16	Oxthera Intellectual Property Ab	مدرات الافراز مشتقة من اوكسالوباكتير فورميجينيس
MX2016002819A (es)	2013-12-03	2016-06-22	Kyowa Chem Ind Co Ltd	Hidrotalcita magnetica compuesta y metodo de produccion de la misma.
AU2016244121B2 (en)	2015-04-02	2020-11-05	Orenzymes Llc	High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
TN2018000420A1 (en)	2016-06-13	2020-06-15	Oxthera Intellectual Property Ab	Compositions and methods for the treatment or prevention of oxalate-related disorders
US10927402B2 (en)	2018-04-10	2021-02-23	Stem Arts Projects, Llc	Capsule for lyophilized reagent storage and delivery
US12016899B2 (en)	2018-07-18	2024-06-25	The University Of Chicago	Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
US12421518B2 (en)	2018-12-10	2025-09-23	Tenza, Inc.	Methods and compositions for treating hyperoxaluria
WO2022140538A1 (en) *	2020-12-23	2022-06-30	Massachusetts Institute Of Technology	Modified bacterium for oxalate degradation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4747397A (en)	1986-06-12	1988-05-31	Magovern George J	Flexible pad for direct myocardial tissue massage having thumb loop
US5286495A (en) *	1992-05-11	1994-02-15	University Of Florida	Process for microencapsulating cells
BR9307548A (pt) *	1992-11-30	1999-06-01	Zeneca Ltd	Fragmento de dna isolado molécula recombinante célula de planta transformada oxalato decarboxilase composição processo para proteger uma planta de ácido oxálico e planta
EP0764204B1 (de)	1994-05-18	2001-08-22	Human Genome Sciences, Inc.	HUMANE OXALYL-CoA DECARBOXYLASE
US6090628A (en)	1994-06-20	2000-07-18	University Of Florida	Materials and methods for detection of Oxalobactor formigenes
US5604111A (en) *	1994-06-20	1997-02-18	University Of Florida Research Foundation	Method and kit for detection of oxalate

1998
- 1998-05-22 ES ES98923673T patent/ES2334409T3/es not_active Expired - Lifetime
- 1998-05-22 CA CA2288709A patent/CA2288709C/en not_active Expired - Lifetime
- 1998-05-22 EP EP98923673A patent/EP0983076B1/de not_active Expired - Lifetime
- 1998-05-22 PT PT98923673T patent/PT983076E/pt unknown
- 1998-05-22 JP JP55067598A patent/JP4996780B2/ja not_active Expired - Lifetime
- 1998-05-22 WO PCT/US1998/010495 patent/WO1998052586A1/en not_active Ceased
- 1998-05-22 US US09/083,362 patent/US6200562B1/en not_active Expired - Lifetime
- 1998-05-22 KR KR1019997010810A patent/KR20010012845A/ko not_active Ceased
- 1998-05-22 DE DE69841200T patent/DE69841200D1/de not_active Expired - Lifetime
- 1998-05-22 EP EP08168165A patent/EP2033651A1/de not_active Withdrawn
- 1998-05-22 AU AU75907/98A patent/AU7590798A/en not_active Abandoned
- 1998-05-22 AT AT98923673T patent/ATE444073T1/de active
2009
- 2009-12-30 CY CY20091101351T patent/CY1109695T1/el unknown
2010
- 2010-10-22 JP JP2010237464A patent/JP2011063597A/ja active Pending

Also Published As

Publication number	Publication date
ES2334409T3 (es)	2010-03-09
EP2033651A1 (de)	2009-03-11
DE69841200D1 (de)	2009-11-12
EP0983076B1 (de)	2009-09-30
CA2288709A1 (en)	1998-11-26
KR20010012845A (ko)	2001-02-26
PT983076E (pt)	2010-01-05
EP0983076A1 (de)	2000-03-08
CA2288709C (en)	2010-05-18
WO1998052586A1 (en)	1998-11-26
JP2011063597A (ja)	2011-03-31
JP2001526690A (ja)	2001-12-18
AU7590798A (en)	1998-12-11
US6200562B1 (en)	2001-03-13
JP4996780B2 (ja)	2012-08-08
CY1109695T1 (el)	2014-08-13

Legal Events

Date

Code

Title

Description

2010-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0983076

Country of ref document: EP

Publication	Publication Date	Title
CY1109695T1 (el)	2014-08-13	Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
IL112664A0 (en)	1995-05-26	4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
WO2002058684A3 (en)	2003-04-17	Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
IL112667A0 (en)	1995-05-26	6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
BRPI0015533B8 (pt)	2021-05-25	enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação
BR0315688A (pt)	2005-09-06	Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
IL130931A0 (en)	2001-01-28	Small molecules useful in the treatment of inflammatory disease
JO2373B1 (en)	2006-12-12	W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MY124714A (en)	2006-06-30	Enzyme treatment
MXPA03005340A (es)	2004-04-02	Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
FI920206A0 (fi)	1992-01-17	Medicinsk anvaendning, medicinskt foerfarande och preparat.
AU8296987A (en)	1988-06-30	Pharmaceutical composition comprising fluticasone propionate
TW200640944A (en)	2006-12-01	VGF polypeptides and methods of treating VGF-related disorders
MXPA02000680A (es)	2002-07-02	Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
CA2319542A1 (en)	1999-11-11	The treatment of sexual dysfunction in certain patient groups
ATE344664T1 (de)	2006-11-15	Verbesserte methode zur eradikation von helicobacter pylori
WO2002094199A3 (en)	2003-12-24	METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
ATE252383T1 (de)	2003-11-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DK1212072T3 (da)	2004-06-21	Farmaceutisk præparat omfattende eukalyptus- og orangeolie
EP1083927A4 (de)	2002-01-02	Menschliches "minor vault" protein p193
SE9700244D0 (sv)	1997-01-28	Novel antibacterial protein
IL112668A0 (en)	1995-05-26	4-amino 6-substituted mycophenolic acid and derivatives thereof, their preparation and pharmaceutical compositions containing them
IL112666A0 (en)	1995-05-26	4-amino derivatives of 5-substituted mycophenolic acid, their preparation and pharmaceutical compositions containing them